|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2182-2189.
Prepublished online as a Blood First Edition Paper on June 27, 2006; DOI 10.1182/blood-2006-01-010249.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia
Phil J. Ancliff,
Michael P. Blundell,
Giles O. Cory,
Yolanda Calle,
Austen Worth,
Helena Kempski,
Siobhan Burns,
Gareth E. Jones,
Jo Sinclair,
Christine Kinnon,
Ian M. Hann,
Rosemary E. Gale,
David C. Linch, and
Adrian J. Thrasher
From the Department of Haematology, Great Ormond Street Hospital, London; the Department of Haematology, the Molecular Immunology Unit and the Molecular Haematology Unit, Institute of Child Health, University College London; the Department of Biochemistry, School of Medical Sciences, University of Bristol; and the Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom.
Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent bacterial infections, and maturation arrest in the bone marrow. Although many cases have mutations in the ELA2 gene encoding neutrophil elastase, a significant proportion remain undefined at a molecular level. A mutation (Leu270Pro) in the gene encoding the Wiskott-Aldrich syndrome protein (WASp) resulting in an X-linked SCN kindred has been reported. We therefore screened the WAS gene in 14 young SCN males with wild-type ELA2 and identified 2 with novel mutations, one who presented with myelodysplasia (Ile294Thr) and the other with classic SCN (Ser270Pro). Both patients had defects of immunologic function including a generalized reduction of lymphoid and natural killer cell numbers, reduced lymphocyte proliferation, and abrogated phagocyte activity. In vitro culture of bone marrow progenitors demonstrated a profound reduction in neutrophil production and increased levels of apoptosis, consistent with an intrinsic disturbance of normal myeloid differentiation as the cause of the neutropenia. Both mutations resulted in increased WASp activity and produced marked abnormalities of cytoskeletal structure and dynamics. Furthermore, these results also suggest a novel cause of myelodysplasia and that male children with myelodysplasia and disturbance of immunologic function should be screened for such mutations.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Park and D. Cox
Cdc42 Regulates Fc{gamma} Receptor-mediated Phagocytosis through the Activation and Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) and Neural-WASP
Mol. Biol. Cell,
November 1, 2009;
20(21):
4500 - 4508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Klein
Molecular basis of congenital neutropenia
Haematologica,
October 1, 2009;
94(10):
1333 - 1336.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Beel and P. Vandenberghe
G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia
Haematologica,
October 1, 2009;
94(10):
1449 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Blundell, G. Bouma, J. Metelo, A. Worth, Y. Calle, L. A. Cowell, L. S. Westerberg, D. A. Moulding, S. Mirando, C. Kinnon, et al.
Phosphorylation of WASp is a key regulator of activity and stability in vivo
PNAS,
September 15, 2009;
106(37):
15738 - 15743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Salipante, M. E. B. Rojas, B. Korkmaz, Z. Duan, J. Wechsler, K. F. Benson, R. E. Person, H. L. Grimes, and M. S. Horwitz
Contributions to Neutropenia from PFAAP5 (N4BP2L2), a Novel Protein Mediating Transcriptional Repressor Cooperation between Gfi1 and Neutrophil Elastase
Mol. Cell. Biol.,
August 15, 2009;
29(16):
4394 - 4405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome
Blood,
June 18, 2009;
113(25):
6288 - 6295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Velu, A. M. Baktula, and H. L. Grimes
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis
Blood,
May 7, 2009;
113(19):
4720 - 4728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Notarangelo and R. Badolato
Leukocyte trafficking in primary immunodeficiencies
J. Leukoc. Biol.,
March 1, 2009;
85(3):
335 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Boztug, G. Appaswamy, A. Ashikov, A. A. Schaffer, U. Salzer, J. Diestelhorst, M. Germeshausen, G. Brandes, J. Lee-Gossler, F. Noyan, et al.
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
N. Engl. J. Med.,
January 1, 2009;
360(1):
32 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Montoya-Durango, C. S. Velu, A. Kazanjian, M. E. B. Rojas, C. M. Jay, G. D. Longmore, and H. L. Grimes
Ajuba Functions as a Histone Deacetylase-dependent Co-repressor for Autoregulation of the Growth Factor-independent-1 Transcription Factor
J. Biol. Chem.,
November 14, 2008;
283(46):
32056 - 32065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G P Spickett
Immune deficiency disorders involving neutrophils
J. Clin. Pathol.,
September 1, 2008;
61(9):
1001 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Berliner
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Blood,
June 15, 2008;
111(12):
5427 - 5432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Moulding, M. P. Blundell, D. G. Spiller, M. R.H. White, G. O. Cory, Y. Calle, H. Kempski, J. Sinclair, P. J. Ancliff, C. Kinnon, et al.
Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia
J. Exp. Med.,
September 3, 2007;
204(9):
2213 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante
Neutrophil elastase in cyclic and severe congenital neutropenia
Blood,
March 1, 2007;
109(5):
1817 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|